• 1
    Schmidtgayk H, Grawunder C, Tschope W, Schmitt W, Ritz E, Pietsch V, Andrassy K, Bouillon R 1977 25-hydroxy-vitamin-D in nephrotic syndrome. Lancet 2: 105108.
  • 2
    Schneider GB, Benis KA, Flay NW, Ireland RA, Popoff SN 1995 Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 16: 657662.
  • 3
    Yamamoto N, Kumashiro R 1993 Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells. J Immunol 151: 27942802.
  • 4
    Braun A, Bichlmaier R, Cleve H 1992 Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): Allelic differences of the common genetic GC types. Hum Genet 89: 401406.
  • 5
    Yamamoto N, Homma S 1991 Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci USA 88: 85398543.
  • 6
    Cleve H, Constans J 1988 The mutants of the vitamin-D-binding protein: More than 120 variants of the GC/DBP system. Vox Sang 54: 215225.
  • 7
    Kamboh MI, Ferrell RE 1986 Ethnic variation in vitamin D-binding protein (GC): A review of isoelectric focusing studies in human populations. Hum Genet 72: 281293.
  • 8
    Lauridsen AL, Vestergaard P, Nexo E 2001 Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 47: 753756.
  • 9
    Mosekilde L, Hermann AP, Beck-Nielsen H, Charles P, Nielsen SP, Sorensen OH 1999 The Danish Osteoporosis Prevention Study (DOPS): Project design and inclusion of 2000 normal perimenopausal women. Maturitas 31: 207219.
  • 10
    Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H 1995 Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone 16: 385390.
  • 11
    Moller HJ, Hald K, Moestrup SK 2002 Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Scand J Clin Lab Invest 62: 293299.
  • 12
    Brixen K, Nielsen HK, Eriksen EF, Charles P, Mosekilde L 1989 Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: Comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int 44: 9398.
  • 13
    Yamamoto N, Naraparaju VR, Orchard PJ 1996 Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis. Blood 88: 14731478.
  • 14
    Swamy N, Ghosh S, Schneider GB, Ray R 2001 Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D(3) does not influence this activity. J Cell Biochem 81: 535546.
  • 15
    Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK 2001 Identification of the haemoglobin scavenger receptor. Nature 409: 198201.
  • 16
    Moller HJ, Peterslund NA, Graversen JH, Moestrup SK 2002 Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 99: 378380.
  • 17
    Moller HJ, Aerts H, Gronbaek H, Peterslund NA, Hyltoft PP, Hornung N, Rejnmark L, Jabbarpour E, Moestrup SK 2002 Soluble CD163: A marker molecule for monocyte/macrophage activity in disease. Scand J Clin Lab Invest Suppl 62 (237): 2933.
  • 18
    Matsushita N, Kashiwagi M, Wait R, Nagayoshi R, Nakamura M, Matsuda T, Hogger P, Guyre PM, Nagase H, Matsuyama T 2002 Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Clin Exp Immunol 130: 156161.
  • 19
    Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332: 767773.
  • 20
    Riggs BL, Hodgson SF, O'Fallon WM, Chao EY, Wahner HW, Muhs JM, Cedel SL, Melton LJ III 1990 Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322: 802809.
  • 21
    Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD 2002 Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 17: 110.
  • 22
    Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72: 13961409.
  • 23
    Koller DL, Liu G, Econs MJ, Hui SL, Morin PA, Joslyn G, Rodriguez LA, Conneally PM, Christian JC, Johnston CC Jr, Foroud T, Peacock M 2001 Genome screen for quantitative trait loci underlying normal variation in femoral structure. J Bone Miner Res 16: 985991.
  • 24
    Koller DL, White KE, Liu G, Hui SL, Conneally PM, Johnston CC, Econs MJ, Foroud T, Peacock M 2003 Linkage of structure at the proximal femur to chromosomes 3, 7, 8, and 19. J Bone Miner Res 18: 10571065.
  • 25
    Ezura Y, Nakajima T, Kajita M, Ishida R, Inoue S, Yoshida H, Suzuki T, Shiraki M, Hosoi T, Orimo H, Emi M 2003 Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density. J Bone Miner Res 18: 16421649.